Alzheimer's disease and the amyloid cascade hypothesis: Ten years on

Current Opinion in Pharmacology

Volumn 2, Issue 1, 2002, Pages 87-92

  Sommer, Bernd ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CLIOQUINOL; COMPLEMENTARY DNA; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; ENZYME INHIBITOR; GAMMA SECRETASE; IBUPROFEN; INDOMETACIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PRESENILIN 1; PRESENILIN 2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN ANTIBODY; PROTEIN NOTCH; PROTEINASE; SULINDAC SULFIDE; VACCINE;

ALZHEIMER DISEASE; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; DRUG TARGETING; ENZYME ANALYSIS; GENETICS; HUMAN; HYPOTHESIS; IMMUNIZATION; MEDICAL RESEARCH; METABOLISM; MOUSE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; TRANSGENIC MOUSE; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS;

EID: 0036462453     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(01)00126-6     Document Type: Review

References (46)

1. Über eine eigenartige Erkrankung der Hirnrinde
2. Alzheimer's disease: The amyloid cascade hypothesis
3. Translating cell biology into therapeutic advances in Alzheimer's disease
4. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q
5. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
6. Susceptibility locus for Alzheimer's disease on chromosome 10
7. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
8. Purification and cloning of amyloid precursor protein β-secretase from human brain
9. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
10. Identification of a novel aspartic protease (Asp 2) as β-secretase
11. Human asparticprotase memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein
12. A splice variant of β-secretase deficient in the amyloidogenic processing of the amyloid recursor protein
13. Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor
14. Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation
15. BACE1 is the major β-secretase for generation of Aβ peptides for neurons
16. BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: Implications for Alzheimer's disease therapeutics
17. Aβ-generating enzymes: Recent advances in β- and γ-secretase research
18. Secretase targets for Alzheimer's disease: Identification and herapeutic potential
19. A portrait of Alzheimer secretases - New features and familiar faces
20. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
21. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice
22. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
23. Amyloid plaques and neuronal death in APP transgenic mice
24. Recent advances in transgenic model development for Alzheimer's disease
25. Transgenic animals in Alzheimer's disease research
26. Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: Implications for neural system disruption
27. Neurofibrillary pathology in transgenic mice overexpressing V717F beta amyloid precursor protein
28. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
29. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
30. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
31. Tau filament formation in transgenic mice expressing P301L tau
32. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform
33. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
34. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
35. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the DPDAPP mouse
36. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
37. Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease associated pathology in transgenic mice
38. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
39. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
40. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
41. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
42. Uncharged thioflavin-T derivatives bind to amyloid-β protein with high affinity and readily enter the brain
43. In vivo detection of amyloid plaques in a mouse model of Alzeimer's disease
44. Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy
45. Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy
46. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity